ReviewInternational journal of molecular sciences2022

The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer.

Haixia Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.